Gilead’s Yescarta shows benefits for patients with large B-cell lymphoma
This is the most common type of non-Hodgkin lymphoma worldwide
Read More
Section: Research
Vandria announces positive phase 1 data for Alzheimer’s treatment
Trial data showed that VNA-318 has the ability to penetrate the brain
Read More
J&J’s Tremfya improves symptoms of psoriatic arthritis including joint damage
Psoriatic arthritis can develop in up to 30% of people with psoriasis
Read More
Merck KGaA given FDA Fast Track designation for generalised myasthenia gravis drug
Cladribine capsules could become the first ever oral treatment for gMG
Read More
Pfizer’s PADCEV gets FDA approval for bladder cancer
Bladder cancer affects more than 614,000 people globally each year
Read More